NCT01755637View on ClinicalTrials.gov

Bioequivalence Study of Albendazole 400 mg Tablets in Chinese Population

PHASE1CompletedINTERVENTIONAL

Enrollment

56

Participants

Timeline

Start Date

April 30, 2012

Primary Completion Date

April 30, 2012

Study Completion Date

June 30, 2012

Conditions

Helminthiasis

Interventions

DRUG

Albendazole

Albendazole tablets 400 mg

Trial Locations (2)

100049

Central Hospital of China Aerospace Corporation, Beijing

430030

Tongji Hospital, Medical College Huazhong, Wuhan

Sponsors

Lead Sponsor

GlaxoSmithKline

All Listed Sponsors

lead

GlaxoSmithKline

INDUSTRY

NCT01755637 - Bioequivalence Study of Albendazole 400 mg Tablets in Chinese Population | Biotech Hunter | Biotech Hunter